Search research articles
Contact Us
Filters
Showing results (11-20 of 105) with videos related to
Page
of 11
Sort By:
Annual Review of Medicine
|
January 11, 1975
Alterations in T- and B-cells in human disease states
R C Williams, R P Messner
The Journal of Clinical Investigation
|
June 1, 1975
Lymphocytotoxic antibodies in family members of patients with systemic lupus erythematosus
R J DeHoratius, R P Messner
Clinical Immunology and Immunopathology
|
December 1, 1993
Murine complement-mediated immune clearance dysfunction is associated with the lymphoproliferative (lpr) gene
N L Meryhew, R P Messner
Prostaglandins
|
February 1, 1978
Prostaglandin E inhibition of mitogen stimulation in patients with multiple sclerosis
J S Goodwin, R P Messner
The Journal of Rheumatology
|
February 1, 1991
Difluoromethylornithine therapy of female NZB/W mice
T J Thomas, R P Messner
Arthritis and Rheumatism
|
May 1, 1986
Effects of lupus-inducing drugs on the B to Z transition of synthetic DNA
T J Thomas, R P Messner
Clinical Immunology and Immunopathology
|
July 1, 1984
Suppression of human lymphocyte mitogenesis mediated by phagocyte-released reactive oxygen species: comparative activities in normals and in chronic granulomatous disease
D C Zoschke, R P Messner
Clinical and Experimental Immunology
|
November 1, 1989
Beneficial effects of a polyamine biosynthesis inhibitor on lupus in MRL-lpr/lpr mice
T J Thomas, R P Messner
Seminars in Arthritis and Rheumatism
|
February 1, 1975
Recent observations on central nervous system lupus erythematosus
D A Bennahum, R P Messner
Journal of Virology
|
November 13, 1999
Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution
P E Tam, R P Messner
Page
of 11
Search research articles
Search
Showing results (11-20 of 105) with videos related to
Sort By:
Page
of 11
Annual Review of Medicine
|
January 11, 1975
Alterations in T- and B-cells in human disease states
R C Williams, R P Messner
The Journal of Clinical Investigation
|
June 1, 1975
Lymphocytotoxic antibodies in family members of patients with systemic lupus erythematosus
R J DeHoratius, R P Messner
Clinical Immunology and Immunopathology
|
December 1, 1993
Murine complement-mediated immune clearance dysfunction is associated with the lymphoproliferative (lpr) gene
N L Meryhew, R P Messner
Prostaglandins
|
February 1, 1978
Prostaglandin E inhibition of mitogen stimulation in patients with multiple sclerosis
J S Goodwin, R P Messner
The Journal of Rheumatology
|
February 1, 1991
Difluoromethylornithine therapy of female NZB/W mice
T J Thomas, R P Messner
Arthritis and Rheumatism
|
May 1, 1986
Effects of lupus-inducing drugs on the B to Z transition of synthetic DNA
T J Thomas, R P Messner
Clinical Immunology and Immunopathology
|
July 1, 1984
Suppression of human lymphocyte mitogenesis mediated by phagocyte-released reactive oxygen species: comparative activities in normals and in chronic granulomatous disease
D C Zoschke, R P Messner
Clinical and Experimental Immunology
|
November 1, 1989
Beneficial effects of a polyamine biosynthesis inhibitor on lupus in MRL-lpr/lpr mice
T J Thomas, R P Messner
Seminars in Arthritis and Rheumatism
|
February 1, 1975
Recent observations on central nervous system lupus erythematosus
D A Bennahum, R P Messner
Journal of Virology
|
November 13, 1999
Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution
P E Tam, R P Messner
Page
of 11